IL20 (interleukin 20)

2007-02-01  

Identity

HGNC
IL20
LOCATION
1q32.1
LOCUSID
50604
ALIAS
IL-20,IL10D,ZCYTO10

Other Information

Locus ID:

NCBI: 50604
MIM: 605619
HGNC: 6002
Ensembl: ENSG00000162891

Variants:

dbSNP: 50604
ClinVar: 50604
TCGA: ENSG00000162891
COSMIC: IL20

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000162891ENST00000367096Q9NYY1
ENSG00000162891ENST00000367098Q9NYY1
ENSG00000162891ENST00000391930Q9NYY1

Expression (GTEx)

0
1
Adipose - Subcutaneous
Adipose - Visceral
Adrenal Gland
Artery - Aorta
Artery - Tibial
Bladder
Brain - Amygdala
Brain - Anterior cingulate cortex
Brain - Caudate
Brain - Cerebellar Hemisphere
Brain - Cerebellum
Brain - Cortex
Brain - Frontal Cortex
Brain - Hippocampus
Brain - Hypothalamus
Brain - Nucleus accumbens
Brain - Putamen
Brain - Spinal cord
Brain - Substantia nigra
Breast - Mammary Tissue
Cells - Cultured fibroblasts
Cells - EBV - transformed lymphocytes
Cervix - Ectocervix
Cervix - Endocervix
Colon - Sigmoid
Colon - Transverse
Esophagus - Gastroesophageal Junction
Esophagus - Mucosa
Esophagus - Muscularis
Fallopian Tube
Heart - Atrial Appendage
Heart - Left Ventricle
Kidney - Cortex
Kidney - Medulla
Liver
Lung
Minor Salivary Gland
Muscle - Skeletal
Nerve - Tibial
Ovary
Pancreas
Pituitary
Prostate
Skin - Not Sun Exposed
Skin - Sun Exposed
Small Intestine - Terminal Ileum
Spleen
Stomach
Testis
Thyroid
Uterus
Vagina
Whole Blood

Pathways

PathwaySourceExternal ID
Cytokine-cytokine receptor interactionKEGGko04060
Jak-STAT signaling pathwayKEGGko04630
Cytokine-cytokine receptor interactionKEGGhsa04060
Jak-STAT signaling pathwayKEGGhsa04630
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147
Interleukin-19, 20, 22, 24REACTOMER-HSA-8854691

Protein levels (Protein atlas)

Not detected
Low
Medium
High
N/A

References

Pubmed IDYearTitleCitations
378843522024IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.4
383561382024The effect of interleukin-20 on periodontal tissue destruction in individuals with periodontitis.0
378843522024IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.4
383561382024The effect of interleukin-20 on periodontal tissue destruction in individuals with periodontitis.0
356138442023IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis.5
361751832023Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma.1
356138442023IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis.5
361751832023Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma.1
353840092022γ-Secretase inhibitors suppress IL-20-mediated osteoclastogenesis via Notch signalling and are affected by Notch2 in vitro.2
354860042022IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis.5
356812322022Interleukin-20 is involved in dry eye disease and is a potential therapeutic target.12
353840092022γ-Secretase inhibitors suppress IL-20-mediated osteoclastogenesis via Notch signalling and are affected by Notch2 in vitro.2
354860042022IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis.5
356812322022Interleukin-20 is involved in dry eye disease and is a potential therapeutic target.12
344035032021IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation.8

Citation

Dessen P

IL20 (interleukin 20)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46098/gene-explorer/js/lib/hgnc